The "Personalized Medicine" Catalyst: Is 2026 the Year...

added blog Health

2026-02-12 05:20:49 -

The "Personalized Medicine" Catalyst: Is 2026 the Year Electrophoresis Becomes a Bedside Tool?

A major shift in the 2026 global industry is the implementation of "Diagnostic-Grade Electrophoresis" for personalized oncology. This year, to cater to the need for rapid biomarker identification, the Electrophoresis Market has seen a surge in specialized protein profiling systems used directly in hospital pathology labs. This level of "Clinical Integration" is the new gold standard, allowing...

0 Comments 0 Shares 27 Views 0 Reviews